Research Paper Volume 13, Issue 24 pp 25778—25798

PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis


Figure 6. Diagnostic value of PKMYT1 mRNA expression for ccRCC patients in the TCGA dataset. Receiver operating characteristic curves for PKMYT1 to distinguish tumors from normal tissues (A), stage I + II vs. stage III + IV (B), G1&G2 vs. G3&G4 (C), T1&T2 vs. T3&T4 (D), N0 vs. N1 (E), and M0 vs. M1 (F).